Aequita Pharmacy recalls Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Processing Controls.
- Products
-
- Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol
- Company
- Aequita Pharmacy
- Where it was sold
-
MA
States: Massachusetts
- Units affected
- 146 vials
- About this recall
- Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.